Skip to content
Stack & save: 10% off 3+ vials, 15% off 5+ · Free shipping over $250
Cart 0
Compound Files

MOTS-c Research Guide: A Small Peptide in Mitochondrial Signaling

Explore Hero MOTS-c, its mitochondrial research background, metabolic-stress studies, key evidence distinctions, and the documentation needed for a laboratory preparation.

Hero Peptides Research TeamUpdated Nov 20265 min read

Quick facts

Compound MOTS-c
Peptide length 16 amino acids
Research family Mitochondrial-derived peptides
Hero vial sizes 10 mg and 40 mg
Evidence distinction Endogenous measurements and administered material answer different questions
Hero product MOTS-c

MOTS-c is a 16-amino-acid peptide associated with mitochondrial-derived signaling. Research on it connects cellular metabolism, stress responses, and communication with the nucleus. Those themes make it scientifically interesting, but they should not be compressed into a promise about energy, exercise, or longevity.

Hero Peptides lists MOTS-c research material in 10 mg and 40 mg vials. This guide explains its discovery, examines several distinct types of evidence, and describes how to connect the literature to a clearly documented laboratory sample.

MOTS-c. View catalog product

Origin story: a short sequence with a mitochondrial connection

The 2015 discovery paper described MOTS-c as a peptide encoded within the mitochondrial 12S ribosomal RNA region. Experiments included cellular metabolic work and mouse studies. The findings introduced a mitochondrial-derived peptide with effects on metabolic measurements in those systems (Lee et al., 2015).

The full name is mitochondrial open reading frame of the 12S rRNA type-c. It identifies the discovery context. It does not mean a supplied peptide sample is an isolated mitochondrion or a replacement for the many functions mitochondria perform.

For a literature search, retain both MOTS-c and the broader mitochondrial-derived peptide term. When another molecule is described as an analog, record its separate identity. An analog’s results should not be silently assigned to native-sequence MOTS-c.

How MOTS-c is studied: metabolism and stress signaling

The discovery work connected MOTS-c with metabolic pathways, including folate-related metabolism and AMPK signaling. These findings arose from specific experiments; AMPK activation is not a complete account of every possible biological response (Lee et al., 2015).

A later cell-based study examined nuclear localization and changes in gene expression under metabolic stress. It reported movement of MOTS-c into the nucleus in the tested systems. That adds a signaling question beyond simply measuring how much peptide is present (Kim et al., 2018).

In a new experiment, define whether the endpoint concerns localization, gene expression, metabolite abundance, or a functional cellular response. A change in one readout does not establish the others. A diagram linking them should distinguish measured steps from proposed connections.

The mitochondrial-derived peptide explainer places MOTS-c beside related research topics. Shared family membership provides context, while each sequence still needs its own evidence.

Key studies: three evidence layers worth separating

Study Setting Research focus Boundary
Lee et al., 2015 Cell and mouse experiments Metabolic characterization Preclinical findings do not establish human treatment outcomes
Kim et al., 2018 Cell-based experiments Nuclear localization and stress responses Specific models, markers, and conditions
Reynolds et al., 2021 Mouse experiments and human exercise measurements Muscle-related research and endogenous MOTS-c Human measurement is distinct from human peptide administration

The 2021 work combined mouse intervention experiments with measurements around exercise in people. Its human component does not become a trial of administering Hero MOTS-c simply because the same paper contains an intervention in mice (Reynolds et al., 2021).

This distinction is useful far beyond MOTS-c. Measuring a naturally occurring molecule during an activity answers what changed in that setting. Administering a separately prepared molecule asks a different question about exposure, response, and safety.

When summarizing the paper, label each result by model. Avoid one sentence that starts with a mouse intervention and ends by implying a demonstrated human benefit. The change in model is part of the finding’s meaning.

Weak spots: translating observations into conclusions

FDA’s 2026 advisory-committee presentation identifies MOTS-c impurity and immunogenicity concerns, including a lack of clinical studies assessing aggregation or immunogenicity. A positive metabolic readout in cells or mice does not resolve those questions (FDA, 2026).

As of November 17, 2026, this guide does not establish an approved clinical use for Hero MOTS-c. The selected studies support research questions, not claims that the supplied vial improves human performance or extends life.

Endogenous detection also needs careful interpretation. The measured concentration can depend on the specimen and analytical method. Before comparing two reports, check whether they used comparable sample handling, detection techniques, and reporting units.

For administered-material experiments, the source, sequence, purity information, and preparation are separate variables. A published response cannot establish the identity or potency of a new lot. Keep evidence about the biological system separate from evidence about the actual sample.

Handling MOTS-c in the lab

Hero’s 10 mg and 40 mg formats describe nominal mass. Choose preparation conditions from the lot documentation and the requirements of the planned assay. A published experiment can inform the design, but its preparation should not be copied without checking whether the materials and methods match.

For arithmetic only, nominal 10 mg at a final volume of 2 mL gives 5 mg/mL. At a final volume of 4 mL, it gives 2.5 mg/mL. A nominal 40 mg amount at a final volume of 4 mL gives 10 mg/mL. These examples illustrate concentration calculations; they do not establish solvent compatibility or a recommended experimental concentration.

For a later dilution, keep the stock concentration, transferred volume, and final volume visible. Check the unit conversion separately. Record the lot and preparation date alongside the final assay conditions so another researcher can reconstruct the calculation.

The calculator and mass-conversion guide support that arithmetic. The storage guide explains why a generic biological half-life is not a validated solution-stability period.

Hero’s supplied catalog identifies Northfield Analytical for HPLC and mass-spectrometry testing. The COA guide helps distinguish identity and purity information from properties that need additional testing. Assign only results documented for the matching lot.

MOTS-c FAQ

Is MOTS-c a peptide?

Yes. It is described as a 16-amino-acid mitochondrial-derived peptide. That classification does not establish the properties of a particular supplied sample.

Does measuring MOTS-c after exercise prove supplementation works?

No. An endogenous measurement and a controlled administration study address different questions. Retain that distinction when reading research summaries.

Are a MOTS-c analog and MOTS-c interchangeable?

Not by assumption. Structural changes can matter, and evidence should remain attached to the molecule actually studied.

What is Hero MOTS-c?

Hero MOTS-c is Hero Peptides’ MOTS-c research material in 10 mg and 40 mg vials. The product listing and matching lot report provide its supplied specifications.

MOTS-c. View catalog product

References

  1. Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. Source.
  2. Kim KH, et al. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metab. 2018;28(3):516-524.e7. Source.
  3. Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12:470. Source.
  4. U.S. Food and Drug Administration. July 23-24, 2026 Pharmacy Compounding Advisory Committee Meeting, presentation on peptide substances. Reviewed November 17, 2026. Source.
For laboratory research use only. Not for human or veterinary use. This article is educational and is not medical advice.

Read next

Add 3 vials for 10% off
Build my stack